Company Website:
http://www.ksfcounsel.com
NEW ORLEANS -- (Business Wire)
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney
General of Louisiana, Charles C. Foti, Jr., remind investors with large
financial interests that they have only until October 3, 2016 to
file lead plaintiff applications in a securities class action lawsuit
against Keryx Biopharmaceuticals Inc. (NasdaqCM: KERX). Investor losses
must relate to purchases of the Company’s common stock between February
25, 2016, and August 1, 2016. This action is pending in the United
States District Court for the Southern District of New York.
What You May Do
If you purchased shares of Keryx and would like to discuss your legal
rights and how this case might affect you and your right to recover for
your economic loss, you may, without obligation or cost to you, call
toll free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com).
If you wish to serve as a lead plaintiff in this class action by
overseeing lead counsel with the goal of obtaining a fair and just
resolution, you must request this position by application to the Court
by October 3, 2016.
About Kahn Swick & Foti, LLC
KSF, whose partners include the Former Louisiana Attorney General
Charles C. Foti, Jr., is a law firm focused on securities, antitrust and
consumer class actions, along with merger & acquisition and breach of
fiduciary litigation against publicly traded companies on behalf of
shareholders. The firm has offices in New York, California and Louisiana.
To learn more about KSF, you may visit www.ksfcounsel.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160930005039/en/
Contacts:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner,
877-515-1850
lewis.kahn@ksfcounsel.com
Source: Kahn Swick & Foti, LLC
© 2024 Canjex Publishing Ltd. All rights reserved.